Wikidata

(Q61980102)

English

Bortezomib, Arsenic Trioxide, and Melphalan in Treating Patients Undergoing an Autologous Stem Cell Transplant For Multiple Myeloma

clinical trial

In more languages

Statements

title
Phase I Clinical Trial of Dose Escalated Bortezomib + ATO (Arsenic Trioxide) + Melphalan as a Conditioning Regimen for Multiple Myeloma (English)
0 references
medical condition
multiple myeloma
0 references
plasmacytoma
0 references
start time
June 2007
0 references
end time
June 2011
0 references
number of participants
0
0 references
research intervention
bortezomib
0 references
melphalan
0 references
arsenic trioxide
0 references
minimum age
18 year
0 references
maximum age
70 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61980102&oldid=2088226627"